References
- Goda N, Ryan HE, Khadivi B, McNulty W, Rickert RC, Johnson RS. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol Cell Biol 2003; 23:359-69; PMID:12482987; https://doi.org/10.1128/MCB.23.1.359-369.2003
- Warfel NA, El-Deiry WS. HIF-1 signaling in drug resistance to chemotherapy. Curr Med Chem 2014; 21:3021-8; PMID:24735366; https://doi.org/10.2174/0929867321666140414101056
- Warfel NA, Dolloff NG, Dicker DT, Malysz J, El-Deiry WS. CDK1 stabilizes HIF-1alpha via direct phosphorylation of Ser668 to promote tumor growth. Cell Cycle 2013; 12:3689-701; PMID:24189531; https://doi.org/10.4161/cc.26930
- Hubbi ME, Hu H, Kshitiz, Ahmed I, Levchenko A, Semenza GL. Chaperone-mediated autophagy targets hypoxia-inducible factor-1alpha (HIF-1alpha) for lysosomal degradation. J Biol Chem 2013; 288:10703-14; PMID:23457305; https://doi.org/10.1074/jbc.M112.414771
- Mayes PA, Dolloff NG, Daniel CJ, Liu JJ, Hart LS, Kuribayashi K, Allen JE, Jee DI, Dorsey JF, Liu YY, et al. Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3beta and CDK1. Cancer Res 2011; 71:5265-75; PMID:21646472; https://doi.org/10.1158/0008-5472.CAN-11-1383
- Zhang J, Zhou L, Zhao S, Dicker DT, El-Deiry WS. The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia. Cell Cycle 2017; 16(12):1193-1200; PMID:28486050; https://doi.org/10.1080/15384101.2017.1320005
- Rapisarda A, Uranchimeg B, Sordet O, Pommier Y, Shoemaker RH, Melillo G. Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications. Cancer Res 2004; 64:1475-82; PMID:14983893; https://doi.org/10.1158/0008-5472.CAN-03-3139